Cboe Options Exchanges
Cboe provides choice for our diverse trading customers by operating four U.S.-listed cash equity options markets, including the largest options exchange in the U.S. – Cboe Options Exchange.
| Cboe Options Exchange |
|---|
| Hybrid, Classic Model |
| Open outcry and electronic exchange |
| Cboe C2 Options Exchange |
|---|
| Pro-Rata, Maker-Taker Model |
| All-electronic exchange |
| Cboe BZX Options Exchange |
|---|
| Price-Time, Maker-Taker Model |
| All-electronic exchange |
| Cboe EDGX Options Exchange |
|---|
| Classic Pro-Rata/Customer Priority/DMM Model |
| All-electronic exchange |
Cboe Options Exchange Overview
Value of a Physical Trading Floor
Latest News
-
October 7, 2024
Cboe Options Exchanges Restrictions on Transactions in Options on Renalytix Plc (Option Symbol RNLX) Effective October 07, 2024, Renalytix Plc, RNLX will be delisted from the NASDAQ and will move its listing to the Other-OTC Market under symbol RNLXY. Therefore, trading on Cboe Options (C1) Exchange in RNLX and adjusted RNLXY options commencing on October 08, 2024, will be subject to certain restrictions described below. -
October 7, 2024
Cboe Options Exchanges Restrictions on Transactions in Options on Vertex Energy, Inc. (Option Symbol VTNR) Effective October 07, 2024, Vertex Energy, Inc., VTNR will be delisted from the NASDAQ and will move its listing to the Other-OTC Market under symbol VTNRQ. Therefore, trading on Cboe Options (C1) Exchange in VTNR and adjusted VTNRQ options commencing on October 08, 2024, will be subject to certain restrictions described below. Please click title for complete details. -
October 7, 2024
Cboe Options Exchanges Restrictions on Transactions in Options on Trevena, Inc. (Option Symbol TRVN/TRVN1) Effective October 07, 2024, Trevena, Inc., TRVN/TRVN1 will be delisted from the NYSE. Therefore, trading on Cboe Options (C1) Exchange in TRVN/TRVN1 options commencing on October 08, 2024, will be subject to certain restrictions described below. Please click title for complete details. -
October 7, 2024
Update - Cboe BZX Options Introduces 10 Gb Layer 1 Physical Ports Cboe BZX Options Exchange (BZX Options) is pleased to introduce 10 Gb Layer 1 (L1) Physical Ports as an optional service to provide enhanced determinism for BZX Options Depth (PITCH) Market Data delivery effective December 9, 2024, subject to regulatory review. -
October 4, 2024
Cboe Trader E-News for Friday, October 4, 2024 -
October 2, 2024
Cboe Options Exchanges Restrictions on Transactions in Options on Eagle Pharmaceuticals, Inc. (Option Symbol EGRX) Effective October 02, 2024, Eagle Pharmaceuticals, Inc., EGRX will be delisted from the NASDAQ. Therefore, trading on Cboe Options (C1) Exchange in EGRX options commencing on October 03, 2024, will be subject to certain restrictions described below. Please click title for complete details. -
September 30, 2024
Cboe Silexx Announcement – September 30th, 2024 Cboe Silexx is excited to announce the following enhancements. Please click the title for complete details. -
September 30, 2024
Final Reminder - 2024 SIFMA/FIA and Reg SCI BCP/DR Test In coordination with other market centers, as part of the annual SIFMA/FIA industry test and in support of Regulation Systems Compliance and Integrity (SCI) and Cboe Futures Exchange, LLC (CFE) requirements, Cboe is scheduled to host its annual business continuity plan/disaster recovery (BCP/DR) test on Saturday, October 5, 2024. -
September 30, 2024
Schedule Update - Cboe EDGX Options Market Data Performance Improvements Cboe EDGX Options Exchange (EDGX) has rescheduled the remaining performance enhancement upgrades on its market data dissemination systems, which were previously announced. The remaining enhancements will be deployed to EDGX Options market data systems between October 14, 2024, and October 18, 2024. Customers can expect to see lower latency and more consistent performance on all Cboe proprietary market data feeds. -
September 27, 2024
Cboe Options Exchanges Restrictions on Transactions in Options on Telesis Bio, Inc. (Option Symbol TBIO/TBIO1) Effective September 27, 2024, Telesis Bio, Inc., TBIO will be delisted from the NASDAQ. Therefore, trading on Cboe Options (C1) Exchange in TBIO and adjusted TBIO1 options commencing on September 30, 2024, will be subject to certain restrictions described below. Please click title for complete details.